FDA inspection
Triclinic Labs, Inc.: FDA inspection ending Jan 17, 2024
FDA inspection 1227553 · No Action Indicated (NAI) · Lafayette, IN
Key facts
| Inspection ID | 1227553 |
|---|---|
| Firm | Triclinic Labs, Inc. |
| FEI number | 3007799585 |
| Address | 2660 Schuyler Ave Ste A |
| City | Lafayette |
| State | IN |
| ZIP | 47905 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Jan 17, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data